Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004016
Filing Date
2017-05-09
Accepted
2017-05-09 16:56:37
Documents
85
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20170331x10q.htm 10-Q 1514428
2 EX-10.1 arlz-20170331ex101c3bb2d.htm EX-10.1 1537131
3 EX-31.1 arlz-20170331ex31159fed7.htm EX-31.1 15372
4 EX-31.2 arlz-20170331ex312c3ac61.htm EX-31.2 19064
5 EX-32.1 arlz-20170331ex32126e616.htm EX-32.1 11041
6 EX-32.2 arlz-20170331ex3229abc6c.htm EX-32.2 11109
7 GRAPHIC arlz20170331ex101c3bb2d001.jpg GRAPHIC 866
  Complete submission text file 0001558370-17-004016.txt   8633479

Data Files

Seq Description Document Type Size
8 EX-101.INS arlz-20170331.xml EX-101.INS 1490786
9 EX-101.SCH arlz-20170331.xsd EX-101.SCH 62563
10 EX-101.CAL arlz-20170331_cal.xml EX-101.CAL 55915
11 EX-101.DEF arlz-20170331_def.xml EX-101.DEF 244105
12 EX-101.LAB arlz-20170331_lab.xml EX-101.LAB 537003
13 EX-101.PRE arlz-20170331_pre.xml EX-101.PRE 433030
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 17827293
SIC: 2834 Pharmaceutical Preparations